Paediatric Drug Development and Clinical Trials

Event Home

The Venue

FAQs

Welcome to
Paediatric Drug Development and Clinical Trials

Password:

Tuesday 30 September and Wednesday 1 October 2008
The NH Hotel du Grand Sablon, Brussels, Belgium

Paediatric drug development is a highly complex area for drug manufacturers and one which is now obligatory to consider. Before any medicine is authorised for use in adults it must have undergone stringent testing to ensure it is safe an effective. However, this is not the case for medicines for children. In the EU over 50% of medicines used in children have only been studied in adults and the use of off-label prescribing for children can have serious effects.

With the introduction of the medicines in children regulation last year it is now obligatory for all drugs to have trialed and tested paediatric indications, meaning that manufacturers are facing many new challenges. From an update of the legislative framework and case studies of trials in progress to patient recruitment, informed consent and the ethics of paediatric trials, this event will cover the major issues that drug developers are facing today.

VIBevents’ Paediatric Drug Development and Clinical Trials conference will bring case study driven presentations on critical industry-wide issues from leading pharma manufacturers, regulators to the top decision makers. Network with an international audience of fellow drug development and clinical trials professionals and share your views on these important matters.